Division 5.2 Basic studiesF1
United Kingdom
In order to make it possible to correctly interpret the obtained results, it is of greatest importance that the suggested test methods are relevant regarding species sensitivity, administration route, etc. and relevant from a biological and toxicological point of view. The way of administration of the test micro-organism depends on the main exposure routes to humans.
To evaluate medium- and long-term effects after acute, sub-acute or semi-chronic exposure to micro-organisms, it is necessary to use the options provided in the OECD guidelines, to extend the studies concerned with a recovery period (after which full macroscopic and microscopic pathology is to be performed, including an exploration for micro-organisms in the tissues and organs). This facilitates the interpretation of certain effects and provides the possibility to recognise infectiveness and/or pathogenicity, which in turn helps taking decisions on other issues such as the necessity to perform long-term studies (carcinogenicity etc. see point 5.3), and whether or not to perform residue studies (see point 6.2).
- 5.2.1Sensitisation
- 5.2.2Acute toxicity, pathogenicity and infectiveness
- 5.2.3Genotoxicity testing
- 5.2.4Cell culture study
- 5.2.5Information on short-term toxicity and pathogenicity
- 5.2.6Proposed treatment: first aid measures, medical treatment
Annotations
Textual amendments
- F1
Repealed (subject to transitional measures in Arts. 3, 4) by Commission Regulation (EU) No 283/2013 of 1 March 2013 setting out the data requirements for active substances, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market Text with EEA relevance.